These data, collectively, suggest that AuNP-p-CPS62 or AuNP-CPS62 treatment can cause a change in global gene expression profiles in cancer cells, including the downstream targets of c-Myc, meanwhile, may exert their anti-tumor effects by regulating the transcription of other tumor-related genes. The gene discussed is MYC; the disease is cancer.